Gene · 501
Papers3,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer's disease prevention. | Neural Regen Res | 2023 | 37449618 | PubTator, text mining | PubMed |
| CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial. | Neural Regen Res | 2023 | 37449595 | PubTator, text mining | PubMed |
| Structural Optimization of BIPPO Analogs as Potent Antimalarials. | Molecules | 2023 | 37446602 | PubTator, text mining | PubMed |
| Serum 5-Methyltetrahydrofolate Status Is Associated with One-Carbon Metabolism-Related Metabolite Concentrations and Enzyme Activity Indicators in Young Women. | Int J Mol Sci | 2023 | 37446171 | PubTator, text mining | PubMed |
| It Takes Two to Tango! Protein-Protein Interactions behind cAMP-Mediated CFTR Regulation. | Int J Mol Sci | 2023 | 37445715 | PubTator, text mining | PubMed |
| Optical Approaches for Investigating Neuromodulation and G Protein-Coupled Receptor Signaling. | Pharmacol Rev | 2023 | 37429736 | PubTator, text mining | PubMed |
| On pathways and blind alleys-The importance of biomarkers in vitamin B6 -dependent epilepsies. | J Inherit Metab Dis | 2023 | 37428623 | PubTator, text mining | PubMed |
| Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management. | Front Pharmacol | 2023 | 37408757 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
| mScarlet and split fluorophore mScarlet resources for plasmid-based CRISPR/Cas9 knock-in in C. elegans. | MicroPubl Biol | 2023 | 37396790 | PubTator, text mining | PubMed |
| Genomic analysis of multiplex consanguineous families reveals causes of neurodevelopmental disorders with epilepsy. | Gene | 2023 | 37393059 | PubTator, text mining | PubMed |
| Immobilized nanoparticles-mediated enzyme therapy; promising way into clinical development. | Discov Nano | 2023 | 37382752 | PubTator, text mining | PubMed |
| Could Mathematics be the Key to Unlocking the Mysteries of Multiple Sclerosis? | Bull Math Biol | 2023 | 37382681 | PubTator, text mining | PubMed |
| Identifying the Molecular Drivers of Pathogenic Aldehyde Dehydrogenase Missense Mutations in Cancer and Non-Cancer Diseases. | Int J Mol Sci | 2023 | 37373306 | PubTator, text mining | PubMed |
| Future targets for migraine treatment beyond CGRP. | J Headache Pain | 2023 | 37370051 | PubTator, text mining | PubMed |
| Aldehyde-Associated Mutagenesis─Current State of Knowledge. | Chem Res Toxicol | 2023 | 37363863 | PubTator, text mining | PubMed |
| Garcinia kola: a critical review on chemistry and pharmacology of an important West African medicinal plant. | Phytochem Rev | 2023 | 37359709 | PubTator, text mining | PubMed |
| The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review. | Biomol Biomed | 2023 | 37337893 | PubTator, text mining | PubMed |
| Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases. | Front Immunol | 2023 | 37334372 | PubTator, text mining | PubMed |
| A Plasmodium membrane receptor platform integrates cues for egress and invasion in blood forms and activation of transmission stages. | Sci Adv | 2023 | 37327340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/501/papers?page=24